You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

16-1003

Showing 1 - 25 of 5,388
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glabellar Frown Lines Trial in Germany, United Kingdom (Alluzience, powder BoNT-A (BOTOX/Vistabel))

Active, not recruiting
  • Glabellar Frown Lines
  • Alluzience
  • powder BoNT-A (BOTOX/Vistabel)
  • Bochum, Germany
  • +7 more
Sep 9, 2022

Congenital Bleeding Disorder, Haemophilia A Trial in Worldwide (turoctocog alfa pegol)

Completed
Has Results
  • Congenital Bleeding Disorder
  • Haemophilia A
  • turoctocog alfa pegol
  • Phoenix, Arizona
  • +50 more
Nov 3, 2020

Carcinoma, Renal Cell Trial in Worldwide (Pembrolizumab, Favezelimab/Pembrolizumab, Belzutifan)

Recruiting
  • Carcinoma, Renal Cell
  • Pembrolizumab
  • +5 more
  • New Haven, Connecticut
  • +37 more
Jan 25, 2023

Relapsed or Refractory Non-Hodgkin's Lymphoma Trial in China (AXT-1003)

Not yet recruiting
  • Relapsed or Refractory Non-Hodgkin's Lymphoma
  • Beijing, China
  • +3 more
Jul 20, 2023

Papillomavirus Infections Trial in Worldwide (9vHPV Vaccine, Placebo (Saline for Injection))

Active, not recruiting
  • Papillomavirus Infections
  • 9vHPV Vaccine
  • Placebo (Saline for Injection)
  • Northridge, California
  • +102 more
Aug 17, 2022

Pediatric Patients With Solid Tumors Trial in New York, Memphis, Houston (Sentinel Lymph Node Biopsy, indocyanine green (ICG))

Active, not recruiting
  • Pediatric Patients With Solid Tumors
  • Sentinel Lymph Node Biopsy
  • indocyanine green (ICG)
  • New York, New York
  • +2 more
Nov 29, 2021

Eating Disorder, Anorexia Nervosa, Bulimia Nervosa Trial in Louisville (imaginal exposure therapy)

Active, not recruiting
  • Eating Disorder
  • +3 more
  • imaginal exposure therapy
  • Louisville, Kentucky
    Eating Anxiety Treatment Laboratory and Clinic
Oct 4, 2022

Atopic Dermatitis Trial in Worldwide (Tezepelumab, Placebo)

Terminated
Has Results
  • Atopic Dermatitis
  • Fountain Valley, California
  • +85 more
Mar 9, 2022

Epilepsy, Partial Seizures Trial in Worldwide (Pregabalin add-on therapy)

Completed
Has Results
  • Epilepsy, Partial Seizures
  • Pregabalin add-on therapy
  • Tucson, Arizona
  • +85 more
Jan 15, 2021

Healthy Participants Trial (Darigabat, Carbamazepine)

Not yet recruiting
  • Healthy Participants
  • (no location specified)
Apr 11, 2023

Epilepsy Trial in Worldwide (Brivaracetam)

Completed
Has Results
  • Epilepsy
  • Phoenix, Arizona
  • +99 more
Aug 16, 2021

Healthy Growth Trial in New York (New Organic Infant Formula, Commercial Organic Infant Formula)

Recruiting
  • Healthy Growth
  • New Organic Infant Formula
  • Commercial Organic Infant Formula
  • New York, New York
    ObvioHealth
Mar 30, 2023

Patient's Autonomy Vis-à-vis Therapeutic Project Proposed

Active, not recruiting
  • Chronic Pain
    • Paris, France
      Fondation Hôpital Saint-Joseph
    May 26, 2023

    Healthy Subjects Trial in Qingdao (XZP-3621 tablet and itraconazole oral liquid (for Arm1), XZP-3621 tablet and Rifampicin

    Not yet recruiting
    • Healthy Subjects
    • XZP-3621 tablet and itraconazole oral liquid (for Arm1)
    • +2 more
    • Qingdao, Shan Dong, China
      The Affiliated Hospital of Qingdao University
    Oct 16, 2022

    Adolescents Seeking COVID Vaccination (Teen COVID Vax)

    Recruiting
    • Ease Of Access To Covid Vaccine
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Sep 16, 2022

      Non-healing Wound, Diabetic Foot Ulcer Trial in Greenville, Circleville (AC5® Advanced Wound System, Fibracol Plus Collagen

      Recruiting
      • Non-healing Wound
      • Diabetic Foot Ulcer
      • AC5® Advanced Wound System
      • Fibracol Plus Collagen Dressing
      • Greenville, North Carolina
      • +1 more
      Sep 7, 2023

      Cerebral Palsy, Hemiplegia Trial in Valhalla (tDCS plus robotic training)

      Active, not recruiting
      • Cerebral Palsy
      • Hemiplegia
      • tDCS plus robotic training
      • Valhalla, New York
        Kathleen Friel
      Jan 5, 2022

      Atopic Dermatitis Trial in Worldwide (Lebrikizumab, Placebo)

      Completed
      Has Results
      • Atopic Dermatitis
      • Lebrikizumab
      • Placebo
      • Fort Smith, Arkansas
      • +93 more
      Nov 2, 2022

      NASH - Nonalcoholic Steatohepatitis Trial in San Antonio (TERN-501, TERN-101, Placebo)

      Recruiting
      • NASH - Nonalcoholic Steatohepatitis
      • Chandler, Arizona
      • +21 more
      Jan 6, 2023

      Cutaneous Diphtheria in France : Observational, Retrospective

      Not yet recruiting
      • Corynebacterium Diphtheriae Infection
      • Characteristics description
      • Toulon, VAR, France
        HIA Sainte Anne
      Apr 3, 2023

      Overweight and Obesity, Time Restricted Feeding, Alzheimer Trial (Time Restricted Eating intervention, Successful Aging

      Not yet recruiting
      • Overweight and Obesity
      • +2 more
      • Time Restricted Eating intervention
      • Successful Aging Comparison Group (LEARN)
      • (no location specified)
      Feb 17, 2023

      NASH - Nonalcoholic Steatohepatitis Trial in United States (TERN-201, Placebo)

      Active, not recruiting
      • NASH - Nonalcoholic Steatohepatitis
      • Tucson, Arizona
      • +10 more
      Jun 1, 2022

      Gaucher Disease, Type 1 Trial (quantitative chemical shift imaging (QCSI), Elelyso)

      Completed
      • Gaucher Disease, Type 1
      • quantitative chemical shift imaging (QCSI)
      • Elelyso
      • (no location specified)
      Oct 27, 2022

      Atopic Dermatitis Trial in Worldwide (Abrocitinib 200 mg, Dupilumab 300 mg)

      Completed
      Has Results
      • Atopic Dermatitis
      • Abrocitinib 200 mg
      • Dupilumab 300 mg
      • Birmingham, Alabama
      • +150 more
      Jun 9, 2022

      Extensive Stage Small Cell Lung Carcinoma, Limited Stage Small Cell Lung Carcinoma, Neuroendocrine Tumor Trial in Houston (drug,

      Active, not recruiting
      • Extensive Stage Small Cell Lung Carcinoma
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Feb 2, 2022